Search
Powered By HealthLine
Special Offers
Health Tools
 Mammogram Guide
 Check A Breast Cancer Symptom
 Understanding Skin Cancer
 Skin Cancer Q&A
 Prostate Cancer Treatment
Featured Conditions
 Breast Cancer
 Skin Cancer
 Prostate
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Fallout From Atomic Bombs Still Causing Health Problems

Survivors who were children prone to cancers; those not-yet-born a bit luckier, new research suggests

By Alan Mozes
HealthDay Reporter


Related Encyclopedia
 border=
Adenocarcinoma of the Lung and Brain Metastases
Basal Cell Carcinoma
Bladder Cancer
Bone Cancer
More...

Related Healthscout Videos
 border=
Complementary Cancer Care
A Welcome Message from Survivor PJ Hamel
Smother Says "Cut!"
Maryann and Paula
More...

Related Animations
 border=
Breast Self-Exam Video
Colon Cancer
More...

Related Drug Information
 border=
Epogen
Iressa
Procrit
Topamax
More...

Related News Articles
 border=
Ethnicity May Drive Response to Obesity, Insulin Resistance
Smoking, Drinking Should Matter in Movie Ratings, Parent Survey Finds
Wine May Be Protective Against Esophageal Cancer
New Test May Mean Faster Breast Cancer Treatment
More...

FRIDAY, March 14 (HealthDay News) -- Among Japanese survivors of the atomic bombs dropped by the U.S. on Hiroshima and Nagasaki, those exposed to radioactive fallout as young children appear to face a greater risk of developing adult cancers than those exposed while still in the womb, new research suggests.

To date, the risk posed by radiation exposure while in the womb has been a little-studied subject, even though many pregnant women worldwide face radiation exposure through their work or as patients.

Text Continues Below



"Clearly there's an increased risk for adult cancer among all those exposed to radiation, but risk following exposure in utero [in the womb] seems to be quite a bit smaller than risk among those exposed as young children," said study author Dale Preston, a principal scientist with the Hirosoft International Corp., a California-based consulting and software development company.

Preston conducted his study in association with researchers from the U.S. National Cancer Institute and scientists from the Radiation Effects Research Foundation (RERF), located in Hiroshima and Nagasaki. The findings are published in the March 19 issue of the Journal of the National Cancer Institute.

The RERF -- where Preston had previously worked for approximately two decades -- was founded five years after the dropping of the Hiroshima and Nagasaki bombs on Aug. 6 and Aug. 9, 1945, respectively.

Initially called the Atomic Bomb Casualty Commission, the foundation's mission is to examine the long-term impact of radiation exposure among Japan's 120,000-plus survivors of the bombings.

Cancer incidence rates weren't available for the years from 1945 to 1957, so the new study focused on survivors who were between the ages of 12 and 55 between 1958 and 1999. Nearly 2,500 of the male and female participants were in utero when the bombs fell, while nearly 15,500 were below the age of 6 at the time. None had any history of cancer prior to 1958. Radiation dosage exposures were determined, as was proximity of the child and/or pregnant mother to the location of each explosion epicenter.

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 3/14/2008

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Dale Preston, Ph.D., principal scientist, Hirosoft International Corp., Eureka, Calif.; Gerald Crabtree, M.D., professor, pathology and developmental biology and investigator, Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, Calif; March 19, 2008, Journal of the National Cancer Institute


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service   Site Map